Replies to post #169104 on Cytodyn Inc (CYDY)

[DonDonDonDon]

Day 28 mortality data:

LL+SOC: 14 deaths out of 43 patients (32.56%)
Placebo+SOC: 9 deaths out of 19 patients (47.37%)

But we have the raw data for 28 day mortality (from page 19 of the 8-K).

All-cause mortality among critically ill patients was 28% (12/43) with leronlimab + SoC and 37% (7/19) with placebo + SoC at day 28
https://www.cytodyn.com/investors/sec-filings/all-sec-filings/content/0001193125-21-073448/0001193125-21-073448.pdf